Systematic overview of hepatitis C infection in the Middle East and North Africa.
CONCLUSION: A substantial proportion of the reported outcomes may not help policymakers to develop micro-elimination strategies with precise HCV infection prevention and treatment programs in the region, as nowcasting HCV epidemiology using these data is potentially difficult. In addition to providing accurate information on HCV epidemiology, outcomes should also demonstrate practical and clinical significance and relevance. Based on the available data, most countries in the region have low to moderate anti-HCV prevalence. To achieve HCV elimination by 2030, up-to-date, good quality data on HCV epidemiology are required for the GP and key populations such as people who inject drugs and men who have sex with men.
PMID: 30038471 [PubMed - in process]
Source: World Journal of Gastroenterology : WJG - Category: Gastroenterology Authors: Chaabna K, Cheema S, Abraham A, Alrouh H, Lowenfels AB, Maisonneuve P, Mamtani R Tags: World J Gastroenterol Source Type: research
More News: African Health | Algeria Health | Bahrain Health | Children | Djibouti Health | Egypt Health | Epidemiology | Gastroenterology | Hepatitis | Hepatitis B | Hepatitis C | Iraq Health | Jordan Health | Men | Middle East Health | Morocco Health | Pakistan Health | Palestine Health | Qatar Health | Saudi Arabia Health | Study | Sudan Health | Syria Health | Tunisia Health | UAE Health | Yemen Health